The Centers for Disease Control and Prevention has accepted an advisory panel’s recommendations on vaccines for chikungunya disease, which is transmitted to humans by mosquitoes.
The recommendations were made by the health agency’s Advisory Committee on Immunization Practices (ACIP) during a meeting in April, according to the CDC.
ACIP recommended the virus-like particle chikungunya vaccine for people aged 12 or over who are traveling to a country or territory where there is a chikungunya outbreak.
Virus-like particles closely resemble viruses but are not infectious and do not contain genetic material. The panel stated that the virus-like particle vaccine may be considered for people over the age of 12 who are traveling to or residing in a country or territory without an outbreak but with an elevated risk for U.S. travelers if they plan to stay for an extended period of six months or more….